All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2004-003236-59 | Double Blind Placebo Controlled Clinical Investigation into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe Pulmonary Arterial Hypertension Double Blind Placebo... | 2011-07-20 | due-trials |
| Reported results | 2006-000800-17 | A 16-Week International, Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Combination with an Endothelin Re... | 2008-09-29 | due-trials |
| Reported results | 2006-000801-50 | A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects with Pulmonary Arterial H... | 2011-04-29 | due-trials |
| Reported results | 2006-000804-18 | An Open-Label Extension Trial of UT-15C SR in Subjects with Pulmonary Arterial Hypertension | 2020-02-12 | due-trials |
| Reported results | 2008-005018-39 | DISTOL-1:Digital Ischaemic Lesions in Scleroderma treated with Oral Treprostinil Diethanolamine: A randomized, double-blind, placebo controlled, multicenter study | 2011-02-24 | due-trials |
| Reported results | 2008-006978-15 | DISTOL-EXT:Digital Ischaemic Lesions in Scleroderma treated with Oral Treprostinil Diethanolamine: An open-label multicenter extension study | 2011-09-13 | due-trials |
| Reported results | 2009-009366-13 | A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects with Pulmonary Arterial Hypert... | 2012-02-07 | due-trials |
| Reported results | 2011-004631-31 | A 16 Week, Open Label, Multi-Centre, Study to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of a Rapid Dose Titration Regimen of Subcutaneous Remodulin® Therapy in Subjects with Pulmon... | 2014-03-20 | due-trials |
| Reported results | 2012-000097-26 | A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects with Pulmonary Arterial Hypertension Receiving Background Oral M... | 2018-09-26 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2012-000098-21 | An Open Label Extension Study of UT-15C in subjects with Pulmonary Arterial Hypertension- A long term follow up to protocol TDE-PH-310 Studio di estensione in aperto su UT-15C in soggetti con ipert... | 2021-08-12 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2014-003042-27 | An Open-Label Extension Study of APD811-003 in Patients with Pulmonary Arterial Hypertension Az APD811-003 vizsgálat nyílt kiterjesztett vizsgálata pulmonális artériás hipertóniában szenvedő betege... | 2021-03-29 | bad-data |
| Reported results | 2017-000758-20 | A Two-Part, Open-Label, Randomized, Phase II/III Study of Dinutuximab and Irinotecan versus Irinotecan for Second Line Treatment of Subjects with Relapsed or Refractory Small Cell Lung Cancer | 2020-03-27 | due-trials |
| Ongoing | 2018-001187-33 | A StuDy eVAluatiNg the EffiCacy and Safety of RalinEpag To Improve Treatment OUTCOMES in PAH Patients | not-yet-due | |
| Ongoing | 2018-001189-40 | A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION | not-yet-due | |
| Listed as ongoing, but also has a completion date and reported results | 2019-003309-88 | A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Healt... | 2023-04-12 | bad-data |
| Other | 2021-005881-17 | A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (TETON-2) | not-yet-due | |
| Trial is outside EEC, and reported results | 2023-001028-40 | Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study | bad-data |